- Home
- SWX vs PTGX Comparison
SWX vs PTGX Comparison
Compare SWX & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SWX | PTGX |
|---|---|---|
| Founded | 1931 | 2006 |
| Country | United States | United States |
| Employees | 2453 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.4B |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SWX | PTGX |
|---|---|---|
| Price | $88.90 | $101.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $87.40 | ★ $108.23 |
| AVG Volume (30 Days) | 416.9K | ★ 509.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.70% | N/A |
| EPS Growth | ★ 120.29 | N/A |
| EPS | ★ 1.91 | 0.05 |
| Revenue | ★ $5,433,972,000.00 | N/A |
| Revenue This Year | $18.48 | $874.25 |
| Revenue Next Year | $2.61 | N/A |
| P/E Ratio | ★ $45.88 | $2,048.00 |
| Revenue Growth | ★ 9.56 | N/A |
| 52 Week Low | $67.65 | $44.72 |
| 52 Week High | $94.43 | $107.84 |
Technical Indicators
Market Signals| Indicator | SWX | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 44.98 | 50.09 |
| Support Level | $87.84 | $96.20 |
| Resistance Level | $93.93 | $107.42 |
| Average True Range (ATR) | 1.91 | 4.00 |
| MACD | -0.50 | 0.10 |
| Stochastic Oscillator | 20.27 | 49.66 |
Price Performance
Historical ComparisonAbout SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution segment. The Natural gas distribution segment encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. Its division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.